Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times

Dialysis patients are both the most likely to benefit from vaccine protection against SARS-CoV-2 and at the highest risk of not developing an immune response. Data from the medical field are thus mandatory. We report our experience with a BNT162b2-mRNA vaccine in a retrospective analysis of 241 dial...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachelet, Thomas, Bourdenx, Jean-Philippe, Martinez, Charlie, Mucha, Simon, Martin-Dupont, Philippe, Perier, Valerie, Pommereau, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491898/
https://www.ncbi.nlm.nih.gov/pubmed/34610031
http://dx.doi.org/10.1371/journal.pone.0257646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491898/
https://www.ncbi.nlm.nih.gov/pubmed/34610031
http://dx.doi.org/10.1371/journal.pone.0257646

Ejemplares similares